{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T04:17:16Z","timestamp":1778213836427,"version":"3.51.4"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2018,8,6]],"date-time":"2018-08-06T00:00:00Z","timestamp":1533513600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Regional Research Council Uppsala-\u00d6rebro","award":["RFR-226161, RFR 462701"],"award-info":[{"award-number":["RFR-226161, RFR 462701"]}]},{"DOI":"10.13039\/501100006722","name":"Centrum f\u00d6r Klinisk Forskning Dalarna","doi-asserted-by":"publisher","award":["CKFUU-105141, CKFUU-374651, CKFUU-566761"],"award-info":[{"award-number":["CKFUU-105141, CKFUU-374651, CKFUU-566761"]}],"id":[{"id":"10.13039\/501100006722","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007687","name":"Svenska L\u00e4kares\u00e4llskapet","doi-asserted-by":"publisher","award":["SLS-498901, SLS-93191"],"award-info":[{"award-number":["SLS-498901, SLS-93191"]}],"id":[{"id":"10.13039\/501100007687","id-type":"DOI","asserted-by":"publisher"}]},{"name":"EU Interreg ScandTick Innovation","award":["."],"award-info":[{"award-number":["."]}]},{"name":"Division of Laboratory Medicine, Region J\u00f6nk\u00f6ping County","award":["."],"award-info":[{"award-number":["."]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Microbiol Infect Dis"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1007\/s10096-018-3334-3","type":"journal-article","created":{"date-parts":[[2018,8,6]],"date-time":"2018-08-06T09:38:58Z","timestamp":1533548338000},"page":"1983-1991","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["The chemokine CXCL13 in cerebrospinal fluid in children with Lyme neuroborreliosis"],"prefix":"10.1007","volume":"37","author":[{"given":"Anna J.","family":"Henningsson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Malin","family":"Lager","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebecka","family":"Br\u00e4nnstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ivar","family":"Tjernberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9160-1554","authenticated-orcid":false,"given":"Barbro H.","family":"Skogman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,8,6]]},"reference":[{"key":"3334_CR1","doi-asserted-by":"publisher","first-page":"16090","DOI":"10.1038\/nrdp.2016.90","volume":"2","author":"AC Steere","year":"2016","unstructured":"Steere AC et al (2016) Lyme borreliosis. Nat Rev Dis Prim 2:16090","journal-title":"Nat Rev Dis Prim"},{"issue":"9814","key":"3334_CR2","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/S0140-6736(11)60103-7","volume":"379","author":"G Stanek","year":"2012","unstructured":"Stanek G et al (2012) Lyme borreliosis. Lancet 379(9814):461\u2013473","journal-title":"Lancet"},{"issue":"5","key":"3334_CR3","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1097\/QCO.0b013e32832ee880","volume":"22","author":"G Stanek","year":"2009","unstructured":"Stanek G, Strle F (2009) Lyme borreliosis: a European perspective on diagnosis and clinical management. Curr Opin Infect Dis 22(5):450\u2013454","journal-title":"Curr Opin Infect Dis"},{"issue":"3\u20134","key":"3334_CR4","doi-asserted-by":"crossref","first-page":"205","DOI":"10.2119\/2007-00091.Rupprecht","volume":"14","author":"TA Rupprecht","year":"2008","unstructured":"Rupprecht TA et al (2008) The pathogenesis of Lyme neuroborreliosis: from infection to inflammation. Mol Med 14(3\u20134):205\u2013212","journal-title":"Mol Med"},{"issue":"3","key":"3334_CR5","doi-asserted-by":"publisher","first-page":"235","DOI":"10.3109\/07853899609033125","volume":"28","author":"HJ Christen","year":"1996","unstructured":"Christen HJ (1996) Lyme neuroborreliosis in children. Ann Med 28(3):235\u2013240","journal-title":"Ann Med"},{"issue":"6","key":"3334_CR6","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1542\/peds.96.6.1053","volume":"96","author":"PM Bingham","year":"1995","unstructured":"Bingham PM et al (1995) Neurologic manifestations in children with Lyme disease. Pediatrics 96(6):1053\u20131056","journal-title":"Pediatrics"},{"issue":"2","key":"3334_CR7","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1080\/00365540802593453","volume":"41","author":"K Oymar","year":"2009","unstructured":"Oymar K, Tveitnes D (2009) Clinical characteristics of childhood Lyme neuroborreliosis in an endemic area of northern Europe. Scand J Infect Dis 41(2):88\u201394","journal-title":"Scand J Infect Dis"},{"issue":"6","key":"3334_CR8","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1080\/00365540110080421","volume":"34","author":"J Berglund","year":"2002","unstructured":"Berglund J et al (2002) 5-y follow-up study of patients with neuroborreliosis. Scand J Infect Dis 34(6):421\u2013425","journal-title":"Scand J Infect Dis"},{"issue":"11","key":"3334_CR9","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1136\/adc.2009.176529","volume":"95","author":"DM Broekhuijsen-van Henten","year":"2010","unstructured":"Broekhuijsen-van Henten DM, Braun KP, Wolfs TF (2010) Clinical presentation of childhood neuroborreliosis; neurological examination may be normal. Arch Dis Child 95(11):910\u2013914","journal-title":"Arch Dis Child"},{"issue":"1","key":"3334_CR10","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1111\/j.1468-1331.2009.02862.x","volume":"17","author":"A Mygland","year":"2010","unstructured":"Mygland A et al (2010) EFNS guidelines on the diagnosis and management of European Lyme neuroborreliosis. Eur J Neurol 17(1):8\u201316 e1-4","journal-title":"Eur J Neurol"},{"issue":"8","key":"3334_CR11","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1111\/j.1468-1331.2007.01799.x","volume":"14","author":"U Ljostad","year":"2007","unstructured":"Ljostad U, Skarpaas T, Mygland A (2007) Clinical usefulness of intrathecal antibody testing in acute Lyme neuroborreliosis. Eur J Neurol 14(8):873\u2013876","journal-title":"Eur J Neurol"},{"issue":"5","key":"3334_CR12","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1080\/00365540902787666","volume":"41","author":"D Tveitnes","year":"2009","unstructured":"Tveitnes D, Oymar K, Natas O (2009) Laboratory data in children with Lyme neuroborreliosis, relation to clinical presentation and duration of symptoms. Scand J Infect Dis 41(5):355\u2013362","journal-title":"Scand J Infect Dis"},{"issue":"12","key":"3334_CR13","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1097\/INF.0b013e31817fd423","volume":"27","author":"BH Skogman","year":"2008","unstructured":"Skogman BH et al (2008) Lyme neuroborreliosis in children: a prospective study of clinical features, prognosis, and outcome. Pediatr Infect Dis J 27(12):1089\u20131094","journal-title":"Pediatr Infect Dis J"},{"key":"3334_CR14","doi-asserted-by":"crossref","unstructured":"Irani DN (2016) Regulated production of CXCL13 within the central nervous system. J Clin Cell Immunol 7(5):460","DOI":"10.4172\/2155-9899.1000460"},{"key":"3334_CR15","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1186\/1742-2094-9-93","volume":"9","author":"MC Kowarik","year":"2012","unstructured":"Kowarik MC et al (2012) CXCL13 is the major determinant for B cell recruitment to the CSF during neuroinflammation. J Neuroinflammation 9:93","journal-title":"J Neuroinflammation"},{"key":"3334_CR16","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/1742-2094-6-42","volume":"6","author":"TA Rupprecht","year":"2009","unstructured":"Rupprecht TA et al (2009) The chemokine CXCL13 is a key regulator of B cell recruitment to the cerebrospinal fluid in acute Lyme neuroborreliosis. J Neuroinflammation 6:42","journal-title":"J Neuroinflammation"},{"issue":"5","key":"3334_CR17","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1007\/s00415-008-0785-y","volume":"255","author":"U Ljostad","year":"2008","unstructured":"Ljostad U, Mygland A (2008) CSF B--lymphocyte chemoattractant (CXCL13) in the early diagnosis of acute Lyme neuroborreliosis. J Neurol 255(5):732\u2013737","journal-title":"J Neurol"},{"key":"3334_CR18","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1186\/1742-2094-11-103","volume":"11","author":"J Hytonen","year":"2014","unstructured":"Hytonen J et al (2014) CXCL13 and neopterin concentrations in cerebrospinal fluid of patients with Lyme neuroborreliosis and other diseases that cause neuroinflammation. J Neuroinflammation 11:103","journal-title":"J Neuroinflammation"},{"issue":"1","key":"3334_CR19","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1186\/s12974-017-0948-9","volume":"14","author":"MM Remy","year":"2017","unstructured":"Remy MM et al (2017) Cerebrospinal fluid CXCL13 as a diagnostic marker of neuroborreliosis in children: a retrospective case-control study. J Neuroinflammation 14(1):173","journal-title":"J Neuroinflammation"},{"key":"3334_CR20","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1186\/1471-2334-12-344","volume":"12","author":"JP Borde","year":"2012","unstructured":"Borde JP et al (2012) CXCL13 may improve diagnosis in early neuroborreliosis with atypical laboratory findings. BMC Infect Dis 12:344","journal-title":"BMC Infect Dis"},{"key":"3334_CR21","doi-asserted-by":"crossref","unstructured":"Senel M et al (2010) The chemokine CXCL13 in acute neuroborreliosis. J Neurol Neurosurg Psychiatry 81(8):929\u201333","DOI":"10.1136\/jnnp.2009.195438"},{"issue":"12","key":"3334_CR22","doi-asserted-by":"publisher","first-page":"e286","DOI":"10.1097\/INF.0000000000001669","volume":"36","author":"B Barstad","year":"2017","unstructured":"Barstad B et al (2017) Cerebrospinal fluid B-lymphocyte chemoattractant CXCL13 in the diagnosis of acute Lyme neuroborreliosis in children. Pediatr Infect Dis J 36(12):e286\u2013e292","journal-title":"Pediatr Infect Dis J"},{"issue":"5","key":"3334_CR23","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1111\/j.1600-0404.2010.01477.x","volume":"124","author":"N Wutte","year":"2011","unstructured":"Wutte N et al (2011) CXCL13 chemokine in pediatric and adult neuroborreliosis. Acta Neurol Scand 124(5):321\u2013328","journal-title":"Acta Neurol Scand"},{"issue":"5","key":"3334_CR24","doi-asserted-by":"publisher","first-page":"2027","DOI":"10.1128\/JCM.00084-11","volume":"49","author":"ND Burgel van","year":"2011","unstructured":"van Burgel ND et al (2011) Discriminating Lyme neuroborreliosis from other neuroinflammatory diseases by levels of CXCL13 in cerebrospinal fluid. J Clin Microbiol 49(5):2027\u20132030","journal-title":"J Clin Microbiol"},{"issue":"11","key":"3334_CR25","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1111\/apm.12596","volume":"124","author":"AJ Henningsson","year":"2016","unstructured":"Henningsson AJ et al (2016) Evaluation of two assays for CXCL13 analysis in cerebrospinal fluid for laboratory diagnosis of Lyme neuroborreliosis. APMIS 124(11):985\u2013990","journal-title":"APMIS"},{"issue":"2","key":"3334_CR26","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1002\/ana.410300212","volume":"30","author":"K Hansen","year":"1991","unstructured":"Hansen K, Lebech AM (1991) Lyme neuroborreliosis: a new sensitive diagnostic assay for intrathecal synthesis of Borrelia burgdorferi--specific immunoglobulin G, A, and M. Ann Neurol 30(2):197\u2013205","journal-title":"Ann Neurol"},{"issue":"3","key":"3334_CR27","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1007\/s00431-002-1119-1","volume":"162","author":"D Tuerlinckx","year":"2003","unstructured":"Tuerlinckx D et al (2003) Clinical data and cerebrospinal fluid findings in Lyme meningitis versus aseptic meningitis. Eur J Pediatr 162(3):150\u2013153","journal-title":"Eur J Pediatr"},{"issue":"7","key":"3334_CR28","doi-asserted-by":"publisher","first-page":"526","DOI":"10.3109\/00365548.2013.776700","volume":"45","author":"H Sillanpaa","year":"2013","unstructured":"Sillanpaa H et al (2013) Cerebrospinal fluid chemokine CXCL13 in the diagnosis of neuroborreliosis in children. Scand J Infect Dis 45(7):526\u2013530","journal-title":"Scand J Infect Dis"},{"key":"3334_CR29","unstructured":"Rupprecht TA et al (2018) Diagnostic value of cerebrospinal fluid CXCL13 for acute Lyme neuroborreliosis. A systemic review and meta-analysis. Clin Microbiol Infect S1198-743X(18):30342-2"},{"issue":"11","key":"3334_CR30","doi-asserted-by":"publisher","first-page":"2221","DOI":"10.1007\/s10096-017-3049-x","volume":"36","author":"BH Skogman","year":"2017","unstructured":"Skogman BH et al (2017) The recomBead Borrelia antibody index, CXCL13 and total IgM index for laboratory diagnosis of Lyme neuroborreliosis in children. Eur J Clin Microbiol Infect Dis 36(11):2221\u20132229","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"5","key":"3334_CR31","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1016\/j.ttbdis.2018.04.008","volume":"9","author":"M Markowicz","year":"2018","unstructured":"Markowicz M et al (2018) CXCL13 concentrations in cerebrospinal fluid of patients with Lyme neuroborreliosis and other neurological disorders determined by Luminex and ELISA. Ticks Tick Borne Dis 9(5):1137\u20131142","journal-title":"Ticks Tick Borne Dis"}],"container-title":["European Journal of Clinical Microbiology & Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10096-018-3334-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-018-3334-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-018-3334-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,28]],"date-time":"2022-08-28T20:03:11Z","timestamp":1661716991000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10096-018-3334-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,6]]},"references-count":31,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["3334"],"URL":"https:\/\/doi.org\/10.1007\/s10096-018-3334-3","relation":{},"ISSN":["0934-9723","1435-4373"],"issn-type":[{"value":"0934-9723","type":"print"},{"value":"1435-4373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,6]]},"assertion":[{"value":"13 June 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in this study involving human participants (children) were in accordance with the ethical standards of the institutional and\/or national research committee, and with the 1964 Helsinki declaration and its later amendments, or comparable ethical standards. Informed written consent was received from all parents\/guardians in the study, and approval of the study was obtained from the Regional Ethical Review Board in Uppsala, Sweden (Dnr 2010\/106).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed written consent was received from all the included children and\/or their parents\/guardians in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}